Delivery Order SPE2DE21D7020-SPE2D625F0QPB
- Not listed
- This is a fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a global medical technology company headquartered in Marlborough, Massachusetts. The contract, valued at $116,978.14, is for the supply of the ELUVIA Drug Eluting Stent, a specialized cardiovascular medical device. The contract has an ultimate completion date of April 3, 2025 and does not utilize any set-aside designations. Boston Scientific is the prime contractor on this...
- The Defense Logistics Agency Troop Support Medical awarded a $4,232 fixed-price delivery order to Boston Scientific Corporation, doing business as Boston Scientific, for the delivery of ELUVIA drug-eluting stents. The delivery order was issued against an indefinite-delivery/indefinite-quantity contract vehicle and calls for Boston Scientific to provide the stents to the agency between August 1-8, 2023. Performance will occur at Boston Scientific's facility in Marlborough, Massachusetts. No...
- Boston Scientific Corp was awarded a delivery order valued at $4,351.60 for a drug-eluting vascular stent (7mm x 100mm x 130cm) on December 12, 2025, with an ultimate completion date of December 19, 2025. This fixed-price delivery order with economic price adjustment was issued by the Defense Health Agency's Medical Supply Chain division and will be performed in Marlborough, Massachusetts. The award was made without a small business set-aside, allowing Boston Scientific to compete on an...
- This is a $12,794.40 fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corp, a leading manufacturer of medical devices. The contract is for the delivery of the ELUVIA Drug Eluting Stent, a specialized cardiovascular medical device. The contract has an ultimate completion date of August 28, 2024 and does not have a set-aside designation. Boston Scientific is an experienced federal contractor, having received numerous contracts and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a leading manufacturer of medical devices. The $21,316.72 fixed-price contract is for the Eluvia Drug Eluting Stent, a specialized cardiovascular medical device. The contract has an ultimate completion date of December 12, 2024. Boston Scientific is the prime contractor and sole provider for this award, which is not associated with a set-aside program. The contract builds on Boston...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corporation, a leading medical device manufacturer, for the supply of the ELUVIA Drug Eluting Stent. The contract has a ceiling value of $8,464.00 and an ultimate completion date of September 12, 2024. The contract is a fixed-price with economic price adjustment and is not set aside. Boston Scientific, doing business as Boston Scientific, is the prime contractor and the manufacturer of...
- This is a delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Boston Scientific Corporation for the supply of ELUVIA Drug Eluting Stents. The fixed-price contract has a ceiling value of $4,787.60 and an ultimate completion date of August 20, 2024. It was awarded on August 13, 2024 and does not have a set-aside designation. Boston Scientific Corporation is a leading medical device manufacturer that provides a wide range of innovative,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Boston Scientific Corp, doing business as Boston Scientific, for the supply of Eluvia Drug Eluting Stents. The contract has a ceiling value of $19,894.22 and an ultimate completion date of September 27, 2024. It is not set aside for any specific socioeconomic program. Boston Scientific is a leading manufacturer of medical devices that provides innovative, minimally invasive solutions to federal healthcare...
- Boston Scientific Corp, a global medical technology company headquartered in Marlborough, Massachusetts, has been awarded a delivery order valued at $11,312.43 by the Defense Health Agency's Medical Supply Chain program. The contract, awarded on August 14, 2025, with an ultimate completion date of August 21, 2025, utilizes fixed-price pricing with economic price adjustment. The delivery order is to be performed at Boston Scientific's facility in Marlborough, MA, and no small business set-aside...
- The Defense Logistics Agency Troop Support Medical awarded a $4,232 fixed-price delivery order to Boston Scientific Corporation, doing business as Boston Scientific, for the provision of ELUVIA drug-eluting stents. The delivery order was issued against an unspecified governmentwide acquisition contract vehicle. Performance will occur in Marlborough, Massachusetts through August 10, 2023. The award continues the agency's support for medical supplies utilized by the Department of Defense. No...
- SPE2DE21D7020Indefinite Delivery Contract
- SPE2DE21D7020-SPE2D625F0QPBDelivery Order
The Defense Health Agency's Medical Supply Chain awarded a delivery order valued at $11,825 to Boston Scientific Corp for ELUVIA drug-eluting stents. The contract was awarded on August 8, 2025, with an ultimate completion date of August 15, 2025, and carries a fixed-price structure with economic price adjustment terms. This delivery order represents Boston Scientific's continued provision of advanced cardiovascular intervention devices to federal healthcare systems, with performance to be executed at the company's facility in Marlborough, Massachusetts. No set-aside designation was applied to this procurement, indicating open competition in the federal marketplace. Boston Scientific Corp, a global medical technology leader headquartered in Marlborough, Massachusetts, serves as a prime contractor across multiple federal healthcare agencies, including the Department of Veterans Affairs and the Defense Health Agency. The company maintains several indefinite delivery vehicles with federal agencies for specialized medical devices, including a $750,000 blanket purchase agreement with the Defense Health Agency for radiation treatment devices through March 30, 2030. Boston Scientific's federal contract portfolio demonstrates its critical role in supplying cardiovascular, interventional, and diagnostic medical equipment to support federal healthcare missions, with this ELUVIA stent delivery order exemplifying the company's ongoing supply of life-saving medical technologies to the defense health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 8/8/25 |